This report discusses those studies that provided new insights into the pathophysiology, diagnosis, and treatment of 3 important genetic/ metabolic disorders of the liver: Wilson's disease, alpha-1-antitrypsin (alpha-1-AT) deficiency, and progressive familial intrahepatic cholestasis (PFIC), a heterozygous group of conditions.